Brain Tunnelgenix Technologies Corp.
- Industry
- Medical Devices
- Founded Year
- 2006
- Headquarters
- 17501 Biscayne Blvd, Aventura, Florida, 33160, United States
- Employee Count
- 27
Key People
- Marcio Abreu, MD - Co-Founder, Chief Scientific Officer, Head of Scientific Research, President & Board Member
- Maria Altieri - Vice President of Legal Affairs & Board Member
-
Robert Mogel - President and Chief Executive Officer
Email: rmogel@bttcorp.com
- Paul A. Caiafa - President
- Ricardo Faria - Project Manager
- Marc Abreu - President
- Mohammad Machhour - Design Quality Engineer
- Kathleen O'Connell - Director of Media and Strategic Partnerships
- Javkhlantugs Mudgil - Director of Engineering
- Mrcio Dultra - Lead Product Designer
- Alfredo Menocal - Laboratory Manager
- Helen Bolduc - Head of Human Resources
- Eduardo Kern - Senior Software Developer
- Fatemeh Sarani Rad - Data Analyst Intern
Assessment
- Team
-
Aspect: First-time physician innovator
Summary: The leadership team includes experienced professionals with backgrounds in medical research and business operations.
The team comprises individuals with significant experience in medical research and business management, contributing to informed decision-making and strategic planning.
- Clinical Need
-
Aspect: Strong
Summary: The company's non-invasive brain temperature monitoring addresses critical needs in managing neurodegenerative diseases.
By providing continuous, non-invasive brain temperature monitoring, the company addresses a vital need in the management and research of conditions like Alzheimer's and Parkinson's diseases.
- Competition
-
Aspect: First mover
Summary: The company appears to be a pioneer in non-invasive continuous brain temperature monitoring.
As the first to introduce non-invasive continuous brain temperature monitoring, the company holds a unique position in the market, potentially leading to early adoption and brand recognition.
- Technical Challenge
-
Aspect: Moderate
Summary: Developing accurate non-invasive monitoring devices presents moderate technical challenges.
Ensuring the accuracy and reliability of non-invasive monitoring devices involves overcoming technical hurdles, which may impact development timelines and resource allocation.
- Patent
-
Aspect: Very Strong
Summary: The company holds a robust portfolio of patents related to its technology.
With over 60 patents and applications in multiple countries, the company secures its technological innovations, providing a barrier to entry for competitors and potential for licensing opportunities.
- Financing
-
Aspect: Medium
Summary: The company has secured funding but may require additional capital for expansion.
While the company has raised funds, further capital infusion will likely be needed to support product development, regulatory approvals, and market expansion efforts.
- Regulatory
-
Aspect: Pivotal Trial
Summary: The company is progressing through pivotal trials for regulatory approval.
Navigating the regulatory landscape requires substantial time and resources, and delays can impact product launch timelines and revenue generation.
Opportunity Rollup
- Odds of Success
- 3.7
- Peak Market Share
- 5.25
- Segment CAGR
- 4.9%
- Market Segment
- Neurology Devices
- Market Sub Segment
- Patient Monitoring
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.26 |
| 2 | 0.79 |
| 3 | 1.84 |
| 4 | 3.68 |
| 5 | 5.25 |
Key Takeaway
Brain Tunnelgenix Technologies Corp. is pioneering non-invasive brain temperature monitoring, addressing a significant clinical need with a strong patent portfolio and experienced leadership, though it faces challenges in financing and regulatory approval processes.